Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Assets (2016 - 2025)

Historic Return on Assets for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.0%.

  • Aytu Biopharma's Return on Assets rose 100.0% to 0.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.01% for FY2025, which is 300.0% up from last year.
  • Aytu Biopharma's Return on Assets amounted to 0.0% in Q4 2025, which was up 100.0% from 0.0% recorded in Q3 2025.
  • Aytu Biopharma's 5-year Return on Assets high stood at 0.0% for Q2 2025, and its period low was 0.71% during Q2 2022.
  • Its 5-year average for Return on Assets is 0.21%, with a median of 0.12% in 2023.
  • In the last 5 years, Aytu Biopharma's Return on Assets crashed by -4900bps in 2022 and then skyrocketed by 5900bps in 2023.
  • Quarter analysis of 5 years shows Aytu Biopharma's Return on Assets stood at 0.37% in 2021, then plummeted by -42bps to 0.53% in 2022, then skyrocketed by 84bps to 0.09% in 2023, then skyrocketed by 87bps to 0.01% in 2024, then soared by 108bps to 0.0% in 2025.
  • Its Return on Assets stands at 0.0% for Q4 2025, versus 0.0% for Q3 2025 and 0.0% for Q2 2025.